This inventor holds 2 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Provincia Italiana Della Congregazione Dei Figli Dell'immacolata Concezione—instituto Dermopatico Dell'immacolata, Provincia Italiana Della Congregzaione Dei Figli Dell'immacolata Concezione - Istituto Dermopatico Dell'immacolata. Active years: 2003-2006.
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2003-2006
Title: The Innovative Contributions of Francesco Facchiano
Introduction
Francesco Facchiano is a notable inventor based in Rome, Italy. He has made significant contributions to the field of biomedical research, particularly in the development of novel peptides and non-peptidic molecules. With a total of 2 patents, his work focuses on inhibiting critical growth factors that play a role in various cellular processes.
Latest Patents
Facchiano's latest patents include a peptide that inhibits platelet-derived growth factor (PDGF-BB) and fibroblast growth factor (bFGF) activity. This innovative peptide, derived from human fibroblast growth factor, has shown the ability to inhibit the effects of PDGF-BB and bFGF on primary rat smooth muscle cells and primary bovine endothelial cells in vitro. Additionally, it has demonstrated the capacity to inhibit angiogenesis in vivo in CD1 mice. Another significant patent involves RGD-analog non-peptidic molecules that possess anti-adhesive, anti-migration, and anti-proliferative effects. These novel molecules mimic the RGD peptide, which is known for its potent inhibitory effects on cellular adhesion, and have proven effective in inhibiting the adhesion, proliferation, and migration of rat smooth muscle cells in vitro.
Career Highlights
Throughout his career, Francesco Facchiano has worked with esteemed organizations such as the Istituto Dermopatico Dell'Immacolata. His research has contributed to advancements in understanding cellular behavior and the development of therapeutic strategies.
Collaborations
Facchiano has collaborated with notable colleagues, including Antonio Facchiano and Ivan Rossi. Their combined expertise has furthered the impact of their research in the biomedical field.
Conclusion
Francesco Facchiano's innovative work in developing peptides and non-peptidic molecules has made a significant impact in biomedical research. His contributions continue to pave the way for advancements in therapeutic applications.